Pharmacologic induction of <scp>PGC</scp> ‐1α stimulates fetal haemoglobin gene expression-Reference-Cited by-同舟云学术

Pharmacologic induction of PGC ‐1α stimulates fetal haemoglobin gene expression

Published:2022-02-04 Issue:1 Volume:197 Page:97-109
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Sun Yanan¹,Habara Alawi¹²^ORCID,Le Cuong Quang¹,Nguyen Nicole³,Chen Raymon³,Murphy George J.¹⁴,Chui David H. K.¹^ORCID,Steinberg Martin H.¹^ORCID,Cui Shuaiying¹^ORCID

Affiliation:

1. Department of Medicine, Section of Hematology‐Medical Oncology Boston University School of Medicine, Boston Medical Center Boston Massachusetts USA

2. Department of Clinical Biochemistry Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia

3. Sargent College of Health and Rehabilitation Sciences Boston University Boston Massachusetts USA

4. Center for Regenerative Medicine Boston University, Boston Medical Center Boston Massachusetts USA

Funder

National Institutes of Health

Doris Duke Charitable Foundation

Pfizer

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18042

Reference47 articles.

1. Minireview: Genetic basis of heterogeneity and severity in sickle cell disease

2. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease

3. Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease

4. Pathophysiology of Sickle Cell Disease

5. Fetal hemoglobin in sickle cell anemia: a glass half full?

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PGC-1α agonism induces fetal hemoglobin and exerts antisickling effects in sickle cell disease;Science Advances;2024-08-02

2. Roles of Nuclear Orphan Receptors TR2 and TR4 during Hematopoiesis;Genes;2024-04-27

3. The state of the art of fetal hemoglobin-inducing agents;Expert Opinion on Drug Discovery;2022-11-02

4. Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective;Pharmaceuticals;2022-06-16

5. Targeting fetal hemoglobin expression to treat β hemoglobinopathies;Expert Opinion on Therapeutic Targets;2022-04-03